Maze Therapeutics, Inc. ($MAZE)
Filing Information
| Accession Number | 0002050167-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
79,500
Total Value
$418,873.24
P&L
+inf% (+$2,737,710.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSBO | Common Stock | โ | Feb 27, 2026 | Exercise/Conversion | 7,500 | $10.42 | $78,150.00 | 18,003 | Direct | โ | View Details | |
CSBO | Common Stock | โ | Feb 27, 2026 | Sale | 3,739 | $45.13 | $168,756.03 | 14,264 | Direct | โ | View Details | |
CSBO | Common Stock | โ | Feb 27, 2026 | Sale | 3,761 | $45.72 | $171,967.21 | 10,503 | Direct | โ | View Details | |
CSBO | Stock Option (Right to Buy) | Derivative | Feb 27, 2026 | Exercise/Conversion | 7,500 | $0.00 | $0.00 | 59,143 | Direct | โ | View Details | |
CSBO | Stock Option (Right to Buy) | Derivative | Mar 2, 2026 | Grant/Award | 38,000 | $0.00 | $0.00 | 38,000 | Direct | โ | View Details | |
CSBO | Restricted Stock Units | Derivative | Mar 2, 2026 | Grant/Award | 19,000 | $0.00 | $0.00 | 19,000 | Direct | โ | View Details |